![]()
|
|
||||||||
J. Biol. Chem., Vol. 280, Issue 44, 36762-36772, November 4, 2005
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
F508-Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Results from Accelerated Endocytosis of
F508-CFTR in Polarized Human Airway Epithelial Cells*
1







From the
Department of Physiology, Dartmouth Medical School, Hanover, New Hampshire 03755,
Department of Pediatrics, University of Florida College of Medicine, Gainesville, Florida 32610, ¶Fukuda Initiative Research Unit, Institute of Physical and Chemical Research (RIKEN), 2-1 Hirosawa, Wako, Saitama, 351-0198, Japan, and ||Department of Biological Sciences, Dartmouth College, Hanover, New Hampshire 03755
The most common mutation in the cystic fibrosis transmembrane conductance regulator (CFTR) gene in individuals with cystic fibrosis,
F508, causes retention of
F508-CFTR in the endoplasmic reticulum and leads to the absence of CFTR Cl- channels in the apical plasma membrane. Rescue of
F508-CFTR by reduced temperature or chemical means reveals that the
F508 mutation reduces the half-life of
F508-CFTR in the apical plasma membrane. Because
F508-CFTR retains some Cl- channel activity, increased expression of
F508-CFTR in the apical membrane could serve as a potential therapeutic approach for cystic fibrosis. However, little is known about the mechanisms responsible for the short apical membrane half-life of
F508-CFTR in polarized human airway epithelial cells. Accordingly, the goal of this study was to determine the cellular defects in the trafficking of rescued
F508-CFTR that lead to the decreased apical membrane half-life of
F508-CFTR in polarized human airway epithelial cells. We report that in polarized human airway epithelial cells (CFBE41o-) the
F508 mutation increased endocytosis of CFTR from the apical membrane without causing a global endocytic defect or affecting the endocytic recycling of CFTR in the Rab11a-specific apical recycling compartment.
Received for publication, August 12, 2005 , and in revised form, August 29, 2005.
* This study was supported by National Institutes of Health Grants P20-RR018787 (to A. S.-U. and B. A. S.) and RO1-DK45881 and RO1-DK34533 (to B. A. S.) from the National Center for Research Resources, a Shwachman Award SWIATE03QO from the Cystic Fibrosis Foundation (to A. S.-U.), and a Research Development Program grant from the Cystic Fibrosis Foundation (to B. A. S.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
1 To whom correspondence should be addressed. Tel.: 603-650-1534; Fax: 603-650-1130; E-mail: Agnieszka.Swiatecka-Urban{at}Dartmouth.edu.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
S. Moreau-Marquis, J. M. Bomberger, G. G. Anderson, A. Swiatecka-Urban, S. Ye, G. A. O'Toole, and B. A. Stanton The {Delta}F508-CFTR mutation results in increased biofilm formation by Pseudomonas aeruginosa by increasing iron availability Am J Physiol Lung Cell Mol Physiol, July 1, 2008; 295(1): L25 - L37. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. W. Musch, A. B. Puffer, and L. Goldstein Volume expansion stimulates monoubiquitination and endocytosis of surface-expressed skate anion-exchanger isoform Am J Physiol Regulatory Integrative Comp Physiol, May 1, 2008; 294(5): R1657 - R1665. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Pochynyuk, J. D. Stockand, and A. Staruschenko Ion Channel Regulation by Ras, Rho, and Rab Small GTPases Experimental Biology and Medicine, November 1, 2007; 232(10): 1258 - 1265. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. S. Ostedgaard, C. S. Rogers, Q. Dong, C. O. Randak, D. W. Vermeer, T. Rokhlina, P. H. Karp, and M. J. Welsh Processing and function of CFTR-{Delta}F508 are species-dependent PNAS, September 25, 2007; 104(39): 15370 - 15375. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Swiatecka-Urban, L. Talebian, E. Kanno, S. Moreau-Marquis, B. Coutermarsh, K. Hansen, K. H. Karlson, R. Barnaby, R. E. Cheney, G. M. Langford, et al. Myosin Vb Is Required for Trafficking of the Cystic Fibrosis Transmembrane Conductance Regulator in Rab11a-specific Apical Recycling Endosomes in Polarized Human Airway Epithelial Cells J. Biol. Chem., August 10, 2007; 282(32): 23725 - 23736. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Wolde, A. Fellows, J. Cheng, A. Kivenson, B. Coutermarsh, L. Talebian, K. Karlson, A. Piserchio, D. F. Mierke, B. A. Stanton, et al. Targeting CAL as a Negative Regulator of {Delta}F508-CFTR Cell-Surface Expression: AN RNA INTERFERENCE AND STRUCTURE-BASED MUTAGENETIC APPROACH J. Biol. Chem., March 16, 2007; 282(11): 8099 - 8109. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. J. Accurso Update in cystic fibrosis 2005. Am. J. Respir. Crit. Care Med., May 1, 2006; 173(9): 944 - 947. [Full Text] [PDF] |
||||
![]() |
Y. Li, W. Wang, W. Parker, and J. P. Clancy Adenosine Regulation of Cystic Fibrosis Transmembrane Conductance Regulator through Prostenoids in Airway Epithelia Am. J. Respir. Cell Mol. Biol., May 1, 2006; 34(5): 600 - 608. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Staub and D. Rotin Role of Ubiquitylation in Cellular Membrane Transport Physiol Rev, April 1, 2006; 86(2): 669 - 707. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Jurkuvenaite, K. Varga, K. Nowotarski, K. L. Kirk, E. J. Sorscher, Y. Li, J. P. Clancy, Z. Bebok, and J. F. Collawn Mutations in the Amino Terminus of the Cystic Fibrosis Transmembrane Conductance Regulator Enhance Endocytosis J. Biol. Chem., February 10, 2006; 281(6): 3329 - 3334. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |